3carprodsandreels|利民股份：根据战略发展规划，公司重点了布局“生物制造”产品方向

Newsletter summary

Limin shares: according to the strategic development plan3carprodsandreelsThe focus of the company3carprodsandreelsThe layout of "biological manufacturing" products to the Securities Times e Company, limin shares (002734) said on the interactive platform on May 5, according to the 2021-2025 strategic development plan, the company is based on its own resource advantages and industry policy guidance.3carprodsandreels.3carprodsandreels..

Text of news flash

Limin shares: according to the strategic development plan, the company focused on the layout of "biological manufacturing" products to the securities times e company news, limin shares (002734) said on the interactive platform on May 5, according to the strategic development plan for 2021-2025, the company based on its own resource advantages and industry policy guidance, focused on the layout of "biological manufacturing" product direction. It mainly includes biological fermentation engineering products, biological semisynthetic products, biological enzyme catalytic products, genetic engineering and other products, and uses the means of synthetic biology (strain transformation, metabolic regulation, separation and purification, polymerization process, application development) to realize the industrialization of new products and the iterative upgrading of traditional fermentation processes and enzymes. Relying on the strong advantages and capabilities of fermentation technology and enzymatic technology, the company is rapidly expanding and extending to new technologies and products in the fields of engineering strains and genetic modification, so as to consolidate and enhance the company's position in the biological manufacturing industry.